Iraqi Kurd Farmers Battle Drought as Lake Dukan Retreats

Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP
Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP
TT

Iraqi Kurd Farmers Battle Drought as Lake Dukan Retreats

Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP
Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP

Farmers in Iraqi Kurdistan seeking to irrigate crops face seeing their economic lifeline slip away as the waters of Lake Dukan recede and dams upstream in Iran stem the flow.

Bapir Kalkani, who is also a trade unionist, farms near the picturesque lake but has seen marked changes over the past three years as Iraq suffers prolonged drought.

"There was water where I'm standing now" in 2019, the 56-year-old said. "It used to go three kilometers (two miles) further, but the level has retreated."

Sesame and beans are being grown on the plain under a blazing sun, adjacent to the lake which is fed by a Tigris tributary, the Lower Zab river which has its source in Iran.

The large artificial lake was created in the 1950s following construction of the Dukan dam, to supply irrigation and drinking water for the region, as well as to generate electricity, AFP reported.

But for several years both the lake and the river have been shrinking -- as have all of the rivers in Iraq.

The country is classified as one of the five nations most vulnerable to the effects of climate change and desertification.

Its water reserves have fallen by 60 percent compared with last year, the government says.

With rainfall becoming a rarity and after three successive years of drought, Iraq has been forced to halve the area it devotes to agriculture.

"If we hadn't had a little rain in late spring, there would have been no crops in Kurdistan this year," Kalkani said.

Farmers in the area used to dig shallow wells fed by the Dukan so they could irrigate their crops. But not any more.

"The wells have lost 70 percent of their water," he said.

Sesame farmer Shirko Aziz Ahmed had to dig a well several meters deep so he could access water and raise it using a diesel-powered pump.

"Sesame needs a lot of watering, so I'm going to have to dig even deeper as the water level goes down," he said.

Drought is not the only source of the farmer's water problems.

Iran has built several dams on the Lower Zab, notably the Kolsa barrage.

"The Kolsa dam has caused at least an 80 percent drop in the water levels" of the Lower Zab, said Banafsheh Keynoush of the Washington-based Middle East Institute.

She said Iran is going through one of the worst droughts in its history and has had to revise its irrigation policy.

"Iran is on a dam-building spree, and many of its dams are small," she told AFP.

The Dukan dam in Iraq has also been badly affected by the reduced river flow, said its director Kochar Jamal Tawfeeq.

"Now we have only 41 percent, below half of the capacity" of the dam, he said.

It supplies drinking water for "about three million people in Sulaymaniyah and Kirkuk", two major cities downstream, he said.

But at just 300 mm (less than 12 inches) of rainfall last year -- half the previous annual average -- the skies have not been generous. And Tawfeeq said 2022 is on track to mirror last year's figures.

"We are releasing 90 cubic meters per second," the director said. "When the reservoir is full, we release 200 to 250."

Tawfeeq said farmers were being told "not to grow crops that need too much water".

He said Baghdad had sent teams to Iran to discuss the reduced flow of the Lower Zab river, but "there's no cooperation from the Iranians".

Iran contends its river flow contribution into the Tigris and Euphrates basin is only about six percent, according to Keynoush.

"What Iran is trying to say is: 'The Euphrates and Tigris problems you have are really between you and Turkey'," where the two main rivers have their sources, she added.

But Iraq itself is not above criticism, said Azzam Alwash, founder of the Nature Iraq non-government organization and presidential adviser.

Iraqi Kurdistan in the north plans to construct new dams but the projects lack any coordination with Baghdad, Alwash said.

Downstream, in central and south Iraq, the situation is being exasperated by a lack of modernization of water resources and could result in disaster, he warned.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”